DOBUTAMINE HYDROCHLORIDE
DOBUTAMINE HYDROCHLORIDE
Approval overview DOBUTAMINE HYDROCHLORIDE is listed in Drugs@FDA under application 216131 (ANDA).
Review priority: STANDARD Marketing status: Prescription Active ingredient DOBUTAMINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 12.5MG BASE/ML Sponsor SLATE RUN PHARMA Submission history Latest submission status date: 2022-12-21 00:00:00.
Structured Monograph
Clinical summary
Approval overview DOBUTAMINE HYDROCHLORIDE is listed in Drugs@FDA under application 216131 (ANDA). Review priority: STANDARD Marketing status: Prescription Active ingredient DOBUTAMINE HYDROCHLORIDE Form and strength INJECTABLE;INJECTION - EQ 12.5MG BASE/ML Sponsor SLATE RUN PHARMA Submission history Latest submission status date: 2022-12-21 00:00:00. Submission type: ORIG.
Monitoring
- • Marketing status: Prescription
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.